Uncommon (may affect up to 1 in 100 people) change in the way food or drink tastes fast pulse injection site reactions such as bruising, pain, irritation, itching and rash
The human evidence is real, it is early, and it is specific: GLP-1 went up, and metabolic benefits showed up mostly in the people who had the most room to improve
Second, subtle digestive changes
The clinical outcomes data is robust and the benefit-risk profile, in appropriate patient populations, is well established
Atopic conditions such as asthma, allergic rhinitis, atopic dermatitis, or food allergies are common in the general population
Progesterone causes water retention during the luteal phase and early menstruation